Solta Clear + Brilliant Touch
Non-Ablative Fractional · 1440nm + 1927nm dual handpiece
The Solta Clear + Brilliant Touch typically sells new in the $50k–$70k range in the US. Solta Clear + Brilliant Touch holds FDA 510(k) clearance for its marketed indication. Figures are market estimates verified August 6, 2026.
What it's actually cleared for: Low-energy fractional diode laser cleared for general dermatologic resurfacing procedures
Last verified: August 6, 2026 · How we verify
New: $50k–$70k|Used: —market estimate, no email required
| Manufacturer | Solta |
|---|---|
| Company | Owner: Bausch Health Companies Inc. (NYSE/TSX: BHC) (subsidiary, since 2014) · Distribution: direct |
| Category | Resurfacing, Tattoo & Vascular |
| Technology | 1440nm + 1927nm dual handpiece |
| FDA status | FDA Cleared |
| New price range | $50k–$70k |
| Used price range | Not published |
| Consumables | Not published |
| Launch year | 2021 |
| Last verified | August 6, 2026 |
Overview
Updated C+B adding Permea 1927 tip
FDA & regulatory status
What it's actually cleared for:
Low-energy fractional diode laser cleared for general dermatologic resurfacing procedures
510(k) numbers
K223647; K110349
Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.
Treatment economics
Economics data for this platform hasn't been published yet.
Chains using this device
No confirmed chain deployments recorded yet.
Owner reviews
Write a reviewNo verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.
Alternatives
History
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Get the full State of Aesthetic Devices 2026 report
The first full census of the US aesthetic device market — preview it free.